The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and molecular characterization of FAP and SPP1 in colorectal cancer (CRC), CALGB (Alliance)/SWOG 80405 and real-world data.
 
Karam Ashouri
No Relationships to Disclose
 
Joshua Millstein
Consulting or Advisory Role - Janssen
 
Yan Yang
No Relationships to Disclose
 
Joanne Xiu
Employment - Caris Life Sciences
 
Shivani Soni
No Relationships to Disclose
 
Priya Jayachandran
No Relationships to Disclose
 
Pooja Mittal
No Relationships to Disclose
 
Sandra Algaze
No Relationships to Disclose
 
Lesly Torres-Gonzalez
No Relationships to Disclose
 
Unnati Shah
No Relationships to Disclose
 
Anthony Shields
Consulting or Advisory Role - Caris Life Sciences; Cogent Biosciences; ImaginAb; Legend Biotech
Speakers' Bureau - Caris Life Sciences
Research Funding - Abbisko Therapeutics (Inst); Alkermes; Amal Therapeutics (Inst); Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Biomedical; Caris Life Sciences; Daiichi Sankyo; Eisai; Esperas Pharma; Esperas Pharma; Exelixis; Five Prime Therapeutics; Gritstone Bio (Inst); H3 Biomedicine; Halozyme; Hutchison China Meditech; IconOVir Bio (Inst); ImaginAb; Incyte; Inovio Pharmaceuticals; Jiangsu Alphamab Biopharmaceuticals; Lexicon; LSK BioPharma; MSK Pharma; Nouscom; Nuvation Bio (Inst); Plexxikon; Repertoire Immune Medicines; Seagen; Shanghai HaiHe Pharmaceutical; Sorrento Therapeutics (Inst); SQZ Biotechnology (Inst); Taiho Pharmaceutical; Telix Pharmaceuticals; TopAlliance BioSciences Inc (Inst); Torque (Inst); Xencor
Travel, Accommodations, Expenses - Caris Life Sciences; GE Healthcare; ImaginAb; Inovio Pharmaceuticals; TransTarget
 
Richard Goldberg
Stock and Other Ownership Interests - Advanced Chemotherapy Technologies; Compass Therapeutics; Quest Diagnostics
Consulting or Advisory Role - Abbvie; Adaptimmune; AstraZeneca; Bayer; Compass Therapeutics; Eisai/H3 Biomedicine; Focal Medical, inc; G1 Therapeutics; GeneCentric; GlaxoSmithKline; Inspira; IQvia; Merck; RIN Institute; Sorrento Therapeutics; Taiho Pharmaceutical; Takeda; UpToDate; Valar Labs
Expert Testimony - Taiho Pharmaceutical
 
Emil Lou
Stock and Other Ownership Interests - Ryght
Honoraria - Boston Scientific; Daiichi Sankyo/UCB Japan (Inst); GlaxoSmithKline; Novocure
Consulting or Advisory Role - Boston Scientific; Novocure; Novocure; Novocure; Novocure
Research Funding - Intima; Novocure
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Minnetronix Medical; NomoCan
 
Benjamin Weinberg
Employment - Apple (I)
Stock and Other Ownership Interests - Apple (I)
Honoraria - Primum
Consulting or Advisory Role - Agenus; AstraZeneca/Daiichi Sankyo; Bayer; DoMore Diagnostics; Foundation Medicine; Merus NV; Regeneron
Speakers' Bureau - Bayer; Daiichi Sankyo/Astra Zeneca; Merus NV; Natera; Seagen; Sirtex Medical; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); BioXCel therapeutics (Inst); Immune System Key (Inst); Ipsen (Inst); Merck (Inst)
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Merus NV
 
John Marshall
Employment - Caris Life Sciences; Indivumed
Leadership - 2curex; Colorectal Cancer Alliance
Honoraria - Arcus Biosciences; Astellas Pharma; AstraZeneca/MedImmune; Bayer/Onyx; Merck; Pfizer; Seagan; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - AstraZeneca; Merck; Pfizer; Seagen; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Merck; Pfizer; Seagan; Taiho Pharmaceutical
Research Funding - Genentech; Natera
 
Shannon Mumenthaler
Employment - Lawrence J. Ellison Institute for Transformative Medicine
Stock and Other Ownership Interests - Abbvie
Research Funding - Lawrence J. Ellison Institute for Transformative Medicine
 
Alan Venook
Consulting or Advisory Role - Abbvie; Amgen; Exact Sciences; Exelixis; INTERA; Pfizer
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
 
Stacey Finley
No Relationships to Disclose
 
Francesca Battaglin
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Abbvie; Adagene; Bayer; Boehringer Ingelheim; Fulgent Genetics; Janssen Oncology; Jazz Pharmaceuticals; Merck Serono; Merus; Roche
Consulting or Advisory Role - 3T BioSciences; Abbvie; Adagene; Bayer; BMS; Fulgent Genetics; GlaxoSmithKline; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; BMS; Merck Serono